Jonathan C. Javitt - Dec 17, 2024 Form 4 Insider Report for NRX Pharmaceuticals, Inc. (NRXP)

Role
Chairman and Chief Scientist, Director, 10%+ Owner
Signature
/s/ Jonathan C. Javitt
Stock symbol
NRXP
Transactions as of
Dec 17, 2024
Transactions value $
$46,800
Form type
4
Date filed
12/18/2024, 08:27 AM
Previous filing
Aug 24, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NRXP Common Stock Purchase $46.8K +40K +89.62% $1.17 84.6K Dec 17, 2024 Direct
holding NRXP Common Stock 1.26M Dec 17, 2024 By the Jonathan Javitt Living Trust F1
holding NRXP Common Stock 142K Dec 17, 2024 By the Javitt 2012 Irrevocable Dynasty Trust F2
holding NRXP Common Stock 30K Dec 17, 2024 By the Jonathan Javitt Donor Advised Fund F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Held by the Jonathan Javitt Living Trust of which the reporting person is the trustee.
F2 Held by the Javitt 2012 Irrevocable Dynasty Trust of which the reporting person is the grantor of such trust. The reporting person is not a trustee or beneficiary of the Trust, and no beneficiary of the Trust resides in the reporting person's household. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
F3 Held by the Jonathan Javitt Donor Advised Fund of which the reporting person is the primary advisor of such fund.